Sony Corp and Olympus Corp said they plan to unveil an ultra high-definition surgical endoscope this week, the first major product from a joint venture formed three years ago. The product allows physicians to view clearer, more instant images of internal organs, aiding precision during surgical procedures, the medical device makers told Reuters ahead of […]

Mylan NV on Monday officially took its takeover bid directly to shareholders of Perrigo Co. (PRGO 0.88 %) after the company’s board and management publicly rebuffed previous advances.   Mylan is offering $75 in cash and 2.3 shares of Mylan for each Perrigo share held, valued at about $187 based on Friday’s closing price. Perrigo’s shares […]

The U.S. Food and Drug Administration (FDA) has banned imports from another India-based drug manufacturing plant over quality control concerns, making it the 10th site in the country this year to face such action.   The FDA’s “import alert” on Mumbai-based Polydrug Laboratories Pvt Ltd’s Ambernath manufacturing plant comes two months after Canada banned the […]

Raptor Pharmaceutical Corp lost more than a third of its market value after the company said it did not plan to develop its liver drug, which failed to meet the main goal in a second mid-stage study. The company’s shares plunged 35.5 percent to $7.61 in premarket trading on Monday. The study was testing the […]

HYDERABAD, India–(BUSINESS WIRE)–Dr. Reddy’s Laboratories (NYSE: RDY) today announced the signing of a commercialization deal with Hatchtech, an Australian pharmaceutical company developing an innovative prescription head lice product, Xeglyze™ Lotion. The exclusive rights for this product are applicable for the territories of the United States, Canada, India, Russia and the CIS, Australia, New Zealand and […]

TOKYO–(BUSINESS WIRE)–PeptiDream Inc., a public Tokyo-based biopharmaceutical company (“PeptiDream”)(TOKYO:4587) today announced a multi-target discovery and optimization collaboration with Sanofi, Paris, France (“Sanofi”)(Euronext: SAN). Under the agreement, PeptiDream will use its proprietary Peptide Discovery Platform System (PDPS) technology to generate macrocyclic/constrained peptides against multiple targets of interest selected by Sanofi. Sanofi will have the right to […]

CHICAGO, Sept. 12, 2015 /PRNewswire/ — Counsel for Takeda and TorHoerman Law, co-lead counsel for Plaintiffs, in the Actos bladder cancer litigation proudly announce today that the settlement agreement reached on April 28, 2015 is final. The Actos settlement is the largest settlement ever for a drug remaining on the market and will compensate over […]

BOSTON – Indianapolis-based Eli Lilly and Company (LLY) will take an additional 6,000 square feet of space in the crowded Kendall Square area magnifying the presence of the company’s new innovation center in the pharmaceutical hub of the east coast, the Boston Business Journal reported this morning.   This addition of space gives Eli Lilly […]

Swiss drugmaker Actelion Ltd has initiated preliminary discussions with U.S. biotech company ZS Pharma Inc, marking the latest bout of deal-making in a healthcare sector that has seen a wave of recent takeovers. Actelion, Europe’s biggest biotech company, and ZS Pharma both issued statements late on Thursday stating that they had held preliminary discussions, but […]

A panel of outside advisers to the U.S. Food and Drug Administration on Thursday voted against approving Purdue Pharma’s opioid painkiller over concerns of overdosing. The recommendation follows comments from the health regulator’s staff on Tuesday on likely errors in administering the experimental drug. The agency’s staff on Wednesday had also highlighted that a rival […]